Dr. Mariko Sato
Claim this profileUniversity of Iowa/Holden Comprehensive Cancer Center
Expert in Brain Tumor
Expert in Tumors
49 reported clinical trials
95 drugs studied
About Mariko Sato
Education:
- Graduated from Tohoku University School of Medicine, Japan.
- Completed Residency at Kapi'olani Medical Center for Women and Children, Honolulu, HI.
- Undertook Fellowships at the University of Utah, Salt Lake City, UT, and in Pediatric Neuro-Oncology at Texas Children's Hospital, Houston, TX.
Experience:
- Served as a Pediatric Cardiologist at Tohoku University of Medicine, Japan.
- Held a Pediatric Hematology/Oncology Fellowship at the University of Utah.
- Became an Associate Professor at the University of Iowa, developing their pediatric neuro-oncology program.
- Currently the Director of the Brain and Spine Tumors Program at CHOC Children's Hospital, Orange County, California.
Area of expertise
1Brain Tumor
Global LeaderStage IV
H3 K27M positive
Stage I
2Tumors
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Mariko Sato is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Mariko Sato
Clinical Trial Related7 years of experience running clinical trials · Led 49 trials as a Principal Investigator · 18 Active Clinical TrialsTreatments Mariko Sato has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Laboratory Biomarker Analysis
- Vincristine Sulfate
- Cytology Specimen Collection Procedure
Breakdown of trials Mariko Sato has run
Brain Tumor
Tumors
Neuroblastoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mariko Sato specialize in?
Mariko Sato focuses on Brain Tumor and Tumors. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are H3 K27M positive.
Is Mariko Sato currently recruiting for clinical trials?
Yes, Mariko Sato is currently recruiting for 13 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Mariko Sato has studied deeply?
Yes, Mariko Sato has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Mariko Sato?
Apply for one of the trials that Mariko Sato is conducting.
What is the office address of Mariko Sato?
The office of Mariko Sato is located at: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa/Holden Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.